Literature DB >> 19468815

Temporary claviculectomy approach for plexiform neurofibroma of the first intercostal nerve.

Tadashi Akiba1, Mamoru Ishiyama, Hideki Marushima, Kimihiro Nojima, Susumu Kobayashi, Toshiaki Morikawa.   

Abstract

Plexiform neurofibroma at the thoracic inlet has rarely been reported and to our knowledge, the use of a temporary middle claviculectomy approach for thoracic inlet tumors has never been reported. We report a case of plexiform neurofibroma of the first intercostal nerve resected using a temporary claviculectomy approach. An abnormal shadow detected radiographically in a 16-year-old boy led to a diagnosis of neurofibromatosis 1 (NF-1) with a chest wall tumor at the thoracic inlet. The patient underwent resection of the tumor with the right first rib. The resected clavicle was reapproximated with a plate and postoperative shoulder function was satisfactory. The tumor was diagnosed pathologically as a plexiform neurofibroma and the patient's postoperative course was uneventful. The temporary middle claviculectomy approach provides excellent exposure of the subclavian vessels and brachial plexus before resection of the tumor. We recommend this approach for tumors of the anterior thoracic inlet.

Entities:  

Mesh:

Year:  2009        PMID: 19468815     DOI: 10.1007/s00595-008-3905-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  12 in total

1.  Thoracic tumors in children with neurofibromatosis-1.

Authors:  E K Schorry; A H Crawford; J C Egelhoff; A M Lovell; H M Saal
Journal:  Am J Med Genet       Date:  1997-09-19

2.  Anterior surgical approaches to the thoracic outlet.

Authors:  M Blair Marshall; John C Kucharczuk; Joseph B Shrager; Larry R Kaiser
Journal:  J Thorac Cardiovasc Surg       Date:  2006-06       Impact factor: 5.209

3.  Transmanubrial osteomuscular sparing approach for apical chest tumors.

Authors:  D Grunenwald; L Spaggiari
Journal:  Ann Thorac Surg       Date:  1997-02       Impact factor: 4.330

4.  Transcervical approach (Dartevelle technique) for resection of lung tumors invading the thoracic inlet, sparing the clavicle.

Authors:  S Nazari
Journal:  J Thorac Cardiovasc Surg       Date:  1996-08       Impact factor: 5.209

5.  Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms.

Authors:  S A Sørensen; J J Mulvihill; A Nielsen
Journal:  N Engl J Med       Date:  1986-04-17       Impact factor: 91.245

6.  Water-clear cell parathyroid adenoma causing primary hyperparathyroidism in a patient with neurofibromatosis type 1: report of a case.

Authors:  Hitomi Kodama; Masatoshi Iihara; Takahiro Okamoto; Takao Obara
Journal:  Surg Today       Date:  2007-09-26       Impact factor: 2.549

7.  Transclavicular approach to the neck, thoracic inlet, and axilla.

Authors:  B C Papsin; J L Freeman; A Davis; R S Bell
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-09

8.  Anterior transcervical-thoracic approach for radical resection of lung tumors invading the thoracic inlet.

Authors:  P G Dartevelle; A R Chapelier; P Macchiarini; B Lenot; J Cerrina; F L Ladurie; F J Parquin; D Lafont
Journal:  J Thorac Cardiovasc Surg       Date:  1993-06       Impact factor: 5.209

9.  Technique for resecting primary and metastatic nonbronchogenic tumors of the thoracic outlet.

Authors:  P Macchiarini; P Dartevelle; A Chapelier; B Lenot; J Cerrina; F L Ladurie; F Parquin
Journal:  Ann Thorac Surg       Date:  1993-03       Impact factor: 4.330

10.  CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions.

Authors:  J H Tonsgard; S M Kwak; M P Short; A H Dachman
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

View more
  1 in total

1.  Mediastinal paraganglioma successfully resected by robot-assisted thoracoscopic surgery with en bloc chest wall resection: a case report.

Authors:  Hiroaki Shidei; Hideyuki Maeda; Tamami Isaka; Takako Matsumoto; Tomoko Yamamoto; Yoji Nagashima; Masato Kanzaki
Journal:  BMC Surg       Date:  2020-03-05       Impact factor: 2.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.